Kolon TissueGene Hopes To Regain Credibility As Stock Trading Resumes

Shares Surge By Daily High

Following its decision to maintain a stock listing for SillaJen earlier this month, the Korea Exchange has done the same for Kolon TissueGene, which had faced delisting but has resumed trading amid decisive moves to improve its business.

Kolon TissueGene Researchers
Korea Exchange Decides To Maintain Kolon TissueGene Listing • Source: Kolon TissueGene Inc.

The Korea Exchange has decided to maintain the stock listing of Kolon TissueGene, Inc., which has resumed trading on the Kosdaq market after the domestic bioventure fulfilled business improvement conditions demanded by the bourse.

It seems investors have also regained their appetite, as the shares surged by their daily limit of 30% to KRW20,850...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from South Korea

More from Focus On Asia